The drug is available as a weight-loss medication under the brand name Wegovy and will now also be sold directly to diabetes ...

Viking Therapeutics stock tumbled after the drugmaker released study results of its experimental weight-loss pill.

Novo Nordisk is teaming up with GoodRx to offer Wegovey and Ozempic for a flat price of $499 a month. Top Air Force general ...

Novo Nordisk (NYSE: NVO) stock is up 2.2% through 10:30 a.m. ET on Viking's bad news. Where to invest $1,000 right now? Our ...

Makers of weight-loss drugs are expected to rake in more than $150 billion in revenue by the early 2030s, thanks to the ...

Viking Therapeutics Inc. plunged in early trading on Tuesday after its experimental obesity pill disappointed in a mid-stage ...

The Ozempic price cut could appease US President Donald Trump, who has pushed for drug companies to lower their prices.

Weight loss before pregnancy linked to lower rates of gestational diabetes and C-sections. Experts discuss implications, limitations, and how to counsel patients.

The viral weight-loss GLP-1 injection is now in the dock with $2 billion lawsuits as patients allege stomach paralysis, ...

The company is the latest facing historic losses as pharmaceutical firms compete to develop a weight-loss pill.

Novo Nordisk is slashing the price of its blockbuster diabetes drug Ozempic for U.S. patients who self-pay or are uninsured.

Novo Nordisk revealed on Monday that US patients can now receive a month’s supply of Ozempic, a highly effective diabetes ...